Patent details
EP2240172 Title: COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
Basic Information
- Publication number:
- EP2240172
- PCT Application Number:
- PCT/US/2008/087336
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088648910
- PCT Publication Number:
- WO/2009/082662
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
- French Title of Invention:
- COMBINAISON DE NILOTINIB ET CHLORAMBUCILE POUR LE TRAITEMENT DE LA LEUCÉMIE LYMPHATIQUE CHRONIQUE
- German Title of Invention:
- KOMBINATION VON NILOTINIB UND CHLORAMBUCIL FÜR DIE BEHANDLUNG VON CHRONISCHER LYMPHOZYTISCHER LEUKÄMIE
- SPC Number:
Dates
- Filing date:
- 18/12/2008
- Grant date:
- 19/03/2014
- EP Publication Date:
- 19/03/2014
- PCT Publication Date:
- 02/07/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/10/2010
- EP B1 Publication Date:
- 19/03/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/12/2014
- Expiration date:
- 18/12/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/12/2008
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- PANASCI Lawrence Carl
- Address:
- Canada (CA)
2
- Name:
- ALOYZ Raquel Silvia
- Address:
- Canada (CA)
Priority
- Priority Number:
- 15704
- Priority Date:
- 21/12/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/196;
| Filing date | Document type | Number of pages |
|---|